Marshall Wace North America’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $443K | Buy |
+17,424
| New | +$443K | ﹤0.01% | 1103 |
|
|
2020
Q4 | – | Sell |
-259,168
| Closed | -$14.3M | – | 1680 |
|
|
2020
Q3 | $14.3M | Sell |
259,168
-276,108
| -52% | -$15.2M | 0.09% | 230 |
|
|
2020
Q2 | $33.8M | Buy |
535,276
+450,108
| +528% | +$28.4M | 0.22% | 114 |
|
|
2020
Q1 | $4.35M | Buy |
85,168
+82,392
| +2,968% | +$4.21M | 0.03% | 345 |
|
|
2019
Q4 | $221K | Sell |
2,776
-5,014
| -64% | -$399K | ﹤0.01% | 953 |
|
|
2019
Q3 | $378K | Buy |
+7,790
| New | +$378K | ﹤0.01% | 851 |
|
|
2018
Q3 | – | Sell |
-132,283
| Closed | -$5.98M | – | 1494 |
|
|
2018
Q2 | $5.98M | Buy |
+132,283
| New | +$5.98M | 0.03% | 471 |
|
|
2017
Q4 | – | Sell |
-22,178
| Closed | -$688K | – | 1683 |
|
|
2017
Q3 | $688K | Buy |
+22,178
| New | +$688K | ﹤0.01% | 1018 |
|
|
2017
Q2 | – | Sell |
-18,751
| Closed | -$694K | – | 1501 |
|
|
2017
Q1 | $694K | Buy |
+18,751
| New | +$694K | 0.01% | 758 |
|